As of 2025-07-09, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 49.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -57.0%.
The range of the Relative Valuation is 38.98 - 56.24 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 29.4x | 26.2x |
| Forward P/E multiples | 18.8x - 22.8x | 21.7x |
| Fair Price | 38.98 - 56.24 | 49.96 |
| Upside | -66.5% - -51.6% | -57.0% |
| Date | P/E |